Catalyst Wire Dossier Catalyst Wire Dossier

Dendritic cell-tumor cell vaccine

dendritic cell-tumor cell vaccine · Genzyme, a Sanofi company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dendritic cell-tumor cell vaccine, covering 2015-03-05 to 2015-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety/Efficacy of a Vaccine Prepared From Dendritic Cells Combined With Tumor Cells to Treat Advanced Kidney Cancer [Phase 1, Phase 2]

See pricing